BONE
MARROW EXAMINATION
Introduction
Bone marrow biopsy is an important and frequently performed invasive
investigation undertaken to diagnose a variety of haematologic and non-haematologic
disease processes and to obtain supportive evidence for the clinical
diagnosis of leukemoid reactions and chronic inflammatory disease. Its
uses also extend to monitoring bone marrow transplants and both the
effects and the effectiveness of chemotherapy and radiation therapy.
NORMALLY IN THIS HOSPITAL, BONE MARROW ASPIRATION AND BIOPSY IS
PERFORMED BY A CONSULTANT HAEMATOLOGIST, OR HEAMATOLOGY REGISTRAR OR
EQUIVALENT WITH APPROPRIATE TRAINING.
1. Bone marrow biopsy indications include:
Evaluation of pancytopenia
Evaluation of possible bone marrow infiltration by leukaemia,
metastatic tumour, lymphoma, granulomas etc).
Diagnosis and staging of solid tumours or lymphoma
Evaluation of selected cases of fever of unknown origin
Diagnosis of systemic amyloidosis when other methods have failed.
Suspected cases of myelofibrosis
Evaluation of myeloproliferative syndromes (polycythemia vera,
essential thrombocythemia etc)
Failed bone marrow aspiration attempts ("dry tap")
2. Bone Marrow Biopsy Needle
The Jamshidi and Islam needles are unquestionably the most popular
and widely used configurations of these needles with documented
efficacy and lack of complications.
- Sites
Bone marrow biopsies can be obtained from many different sites. A
satisfactory sample of marrow core can be obtained from the anterior or
posterior iliac crest. Other sites can also be used. Currently
most bone marrow biopsies are performed at the posterior iliac crest
where in most instances an adequate specimen can be obtained. It
represents the largest readily accessible area of marrow-rich bone in
the body and it is also distant from any vital structure mitigating
potential complications. Also the region can be re-biopsied as often as
every four to six weeks as required for monitoring the marrow following
chemotherapy or other therapeutic modalities. Care however must be taken
while performing this procedure, particularly in obese patients, In
these cases localisation of the posterior iliac crest may be difficult
and trauma to the Sciatic nerve could result.
Bone Marrow Biopsy Needle Procedure
In adults the bone marrow biopsy is usually performed on the right
or left posterior iliac crests.
Place the patient in a right or left lateral decubitus position with
the knee tops drawn up and back comfortably flexed or in a prone
position with a pillow beneath the hips.
Once the area of the posterior iliac crest is located by palpation,
mark the area with thumbnail pressure and prepare the region with
alcohol and iodine, and then drape.
Infiltrate the skin, subcutaneous tissue and periosteum with a local
anaesthetic. Provide ample time for anaesthetic to take effect.
Probe the site with a 21 gauge 1 ˝ inch needle to see if the area
is adequately anaesthetised and roughly to outline the borders of
posterior iliac crest. This also gives an indication as to the depth
at which the bone will be struck and desired angulation of the needle.
Make a small (3mm) skin incision with a pointed scalpel blade over
the marked area.
Hold the needle assembly with its handle rested in the palm, middle
and third finger over the transverse handle, and the index finger
against the shaft of the needle. The application of the index finger
over the shaft helps stabilise the needle and permits proper control.
With the stilette and handle in place – introduce the needle
through the incision and slowly advance it pointing towards the
anterior superior iliac spine.
It is useful to put one hand over the anterior iliac crest with the
middle or index finger on the anterior superior iliac spine. This
approach not only helps stabilise the pelvis and patient in general
but also help in the guidance of the needle towards the anterior
superior iliac spine.
When the posterior iliac crest is reached, it is then penetrated by
a controlled forward thrust and gentle rotary motions of the needle.
Penetration with the stillete in place should be avoided, as it will
reduce the length of the marrow core that will be obtained.
Once the cortex is penetrated, the needle becomes locked in the
cortical bone. The needle is then held in this position with the left
hand while the right hand is used to withdraw the stilette and handle.
Advance the needle gently with slow, steady and controlled clockwise
and counter clockwise rotary motions until an adequate depth is
reached.
Rotate the needle completely several times along its long axis to
sever all the trabecular connections at the base of the marrow core.
Withdraw the needle with a straight pull.
Once the needle is withdrawn the biopsy specimen is removed with a
blunt probe which must be introduced through the distal cutting end of
the needle. During the removal of the specimen, hold the needle and
probe near their tips as this stabilises the needle and the probe,
preventing damage to the cutting end of the needle and helps easy
delivery of the marrow core through the proximal end of the needle.
After the biopsy procedure, press the edges of the wound together
with an adhesive tape. Apply a gauze dressing on the top of the
adhesive tape and instruct the patient to lie on his/her back for 10
to 15 minutes, or longer if the patient has a low platelet count.
5. Specimen Preparation and Findings
The bone marrow aspirate is immediately examined for visible bone
spicules. The presence of these small spicules suggests an adequate
specimen. Direct smears of the aspirate fluid are prepared by the
technologist at the bedside. These smears consist of marrow particles and
free marrow cells spread onto coverslips. This technique helps to preserve
the cytologic appearance of individual blood cells. Bone marrow biopsy
samples are handled differently. In many institutions, touch preparations
are made first, before specimen fixation. The marrow specimen is touched
gently to a clean glass side in several places, without smearing. These
"touch preps" are allowed to air-dry and subsequently undergo
routine staining. This technique also helps preserve cytologic detail.
Once the touch preparations are completed, the remainder of the specimen
is placed in a fixative such as formaline or Zenker’s solution. The
specimen is then processed according to individual laboratory protocol
(for example, overnight fixation, decalcification, wash steps,
dehydration, and serial sectioning). Routine strains are performed on
process specimens. These include hematoxylin and eosin (H & E),
Wright-Giemsa stain, and iron stain. Optional studies may be obtained at a
physician request such as cytogenitic analysis, flow cytometry, electron
microscopy, and amyloid stains. The Haematology Laboratory must be
notified in advance for these studies. Bone marrow specimens may also be
submitted for microbiological analysis. Cultures may be obtained for
aerobic and anaerobic bacterial, fungi (eg, Histoplasma capsulatum),
acid-fast bacilli (eg, Mycobacterium tuberculosis or Mycobacterium
avium-intracellulare), and viruses (cytomegalovirus). Fixatives should not
be added to specimens submitted for culture. Again, it is important to
notify the Microbiology Laboratory in advance for these cultures.
The bone marrow aspirate and biopsy are reviewed by a staff pathologist
or haematologist. The preliminary report on the bone marrow aspirate may
often be available several hours after the procedure, on request. Normal
values for bone marrow cell lines in the adult are as follows:
· |
Blasts: 0% to 1% |
· |
Promyelocytes: 1% to 5% |
· |
Neutrophil myelocytes and metamyelocytes: 7% to 25% |
· |
Neutrophil bands and segs: 20% to 60% |
· |
Eosinophils: 0% to 3% |
· |
Basophils: 0% to 1% |
· |
Monocytes: 0% to 2% |
· |
Lymphocytes: 5% to 15% |
|
|
Erythrocytes |
· |
Proerythrocytes: 0% to 1% |
· |
Early erythrocytes: 1% to 4% |
· |
Late erythrocytes: 10% to 20% |
· |
Normoblasts: 5% to 10% |
|
|
The above bone marrow differential cell counts are calculated
from the bone marrow aspirate specimen. Other useful data provided
by the bone marrow aspirate include: |
· |
Myeloid/erythroid ratio (normal ratio 3-4:1) |
· |
Total cells counted |
· |
Overall cellularity |
· |
Erythropoiesis |
· |
Granulopoiesis |
|
|
The bone marrow biopsy provides additional information on marrow
architecture (which cannot be obtained from the aspirate). When
examining the biopsy specimen, the pathologist may comment on: |
· |
Gross description including size of sample |
· |
Overall cellularity |
· |
Presence of granulomas |
· |
Infiltrative marrow processes such as lymphoma, carcinoma,
granulomas |
· |
Iron stores |
· |
Results of special stains |
6. Complications
Minor complications include local bleeding, haematoma and
discomfort at the needle puncture site. Local infection is rarely seen if
proper patient aftercare is provided.
Major complications have been reported with sternal biopsy, including
fatal puncture of mediasternal structures. Historical reports of fistula
formation, osteomylitis and profuse bleeding have been associated with
biopsy of what are now considered non-standard sites, such as the tibia.
Complications associated with sampling of the iliac crest are however
minimal.
7. Summary
The Bone Marrow Biopsy Needle is now widely accepted as the device of
choice for performing a bone marrow biopsy. Clinical experience has
demonstrated and documented their efficacy and lack of complications.
Nonetheless there remain certain limitations to the use of these
devices that could possibly be addressed by improvements to existing
devices or indeed alternative products;
- The procedure is operator dependent
- Failure of sample retention within the needle is a problem that
necessitates repeat procedures increasing patient trauma and
discomfort
- Sample quantity is occasionally inadequate and compromises
histological evaluation
- Sample quality is occasionally poor either as a result of over
manipulation of the needle and/or as a result of extracting the
specimen from the needle.
Bone marrow sampling is now considered a relatively safe but invasive
procedure.
|